Yahuilong announced that recently, the company received 6 medical device registration certificates for microfluidic chemiluminescence detection reagents issued by the Guangdong Drug Administration, involving high-sensitivity troponin I assay kits, N-terminal B-type natriuretic peptide precursor determination kits, creatine kinase isoenzyme assay kits, myoglobin determination kits, B-type natriuretic peptide determination kits, and D-dimer assay kits. The certified reagent is one of the research tasks of the “14th Five-Year Plan” national key research and development program “High-performance Immune Field Rapid Detection System Development” project undertaken by the company. It is a phased result of the company's research and development of cutting-edge microfluidic control biological testing technology.

Yahuilong announced that recently, the company received 6 medical device registration certificates for microfluidic chemiluminescence detection reagents issued by the Guangdong Drug Administration, involving high-sensitivity troponin I assay kits, N-terminal B-type natriuretic peptide precursor determination kits, creatine kinase isoenzyme assay kits, myoglobin determination kits, B-type natriuretic peptide determination kits, and D-dimer assay kits. The certified reagent is one of the research tasks of the “14th Five-Year Plan” national key research and development program “High-performance Immune Field Rapid Detection System Development” project undertaken by the company. It is a phased result of the company's research and development of cutting-edge microfluidic control biological testing technology.